AU7445601A - Pharmaceutical composition for the treatment of multiple sclerosis - Google Patents

Pharmaceutical composition for the treatment of multiple sclerosis

Info

Publication number
AU7445601A
AU7445601A AU74456/01A AU7445601A AU7445601A AU 7445601 A AU7445601 A AU 7445601A AU 74456/01 A AU74456/01 A AU 74456/01A AU 7445601 A AU7445601 A AU 7445601A AU 7445601 A AU7445601 A AU 7445601A
Authority
AU
Australia
Prior art keywords
treatment
pharmaceutical composition
multiple sclerosis
sclerosis
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU74456/01A
Inventor
Eldad Melamed
Daniel Ophen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mor Research Applications Ltd
Original Assignee
Mor Research Applications Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mor Research Applications Ltd filed Critical Mor Research Applications Ltd
Publication of AU7445601A publication Critical patent/AU7445601A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/428—Thiazoles condensed with carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU74456/01A 2000-06-12 2001-06-12 Pharmaceutical composition for the treatment of multiple sclerosis Abandoned AU7445601A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IL136687 2000-06-12
IL13668700A IL136687A0 (en) 2000-06-12 2000-06-12 Pharmaceutical composition for the treatment of multiple sclerosis
PCT/IL2001/000534 WO2001095907A1 (en) 2000-06-12 2001-06-12 Pharmaceutical composition for the treatment of multiple sclerosis

Publications (1)

Publication Number Publication Date
AU7445601A true AU7445601A (en) 2001-12-24

Family

ID=11074252

Family Applications (1)

Application Number Title Priority Date Filing Date
AU74456/01A Abandoned AU7445601A (en) 2000-06-12 2001-06-12 Pharmaceutical composition for the treatment of multiple sclerosis

Country Status (3)

Country Link
AU (1) AU7445601A (en)
IL (1) IL136687A0 (en)
WO (1) WO2001095907A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6872739B1 (en) 1999-06-04 2005-03-29 Vereniging Voor Christelijk Wetenshappelikjk Onderwijs Use of riluzole for the treatment of multiple sclerosis

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2688138B1 (en) * 1992-03-06 1995-05-05 Rhone Poulenc Rorer Sa APPLICATION OF AMINO-2 TRIFLUOROMETHOXY-6 BENZOTHIAZOLE TO OBTAIN A MEDICINE FOR THE TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS.
CA2375874A1 (en) * 1999-06-04 2000-12-14 Chris Polman Use of riluzole for the treatment of multiple sclerosis

Also Published As

Publication number Publication date
IL136687A0 (en) 2001-06-14
WO2001095907A1 (en) 2001-12-20

Similar Documents

Publication Publication Date Title
AU2001272849A1 (en) Composition for the treatment of osteoarthritis
AU2002313236A1 (en) Medicinal compositions
AU2000276362A1 (en) Composition for the treatment of diabetes
AU2002302147A1 (en) Pharmaceutical composition
AU2002258221A1 (en) Medicinal composition
AU2002240359A1 (en) Pharmaceutical composition for the treatment of alopecia
AU2001290239A1 (en) Medicinal composition
AU2670600A (en) Pharmaceutical composition containing desoxypeganine for the treatment of nicotine dependence
AU4085201A (en) Pharmaceutical composition
AU2002244865A1 (en) Pharmaceutical composition of ibuprofen
AU2002246659A1 (en) Benzoylalkylindolepyridinium compounds and pharmaceutical compositions comprising such compounds
AU2002210286A1 (en) Medicine intended for treatment of multiple sclerosis
AU2002354460A1 (en) Medicinal composition
AU2002246658A1 (en) Benzoylalkylindolepyridinium compounds and pharmaceutical compositions comprising such compounds
AU7445601A (en) Pharmaceutical composition for the treatment of multiple sclerosis
AU2683500A (en) Compositions for the treatment of pain
AU2001278705A1 (en) Pharmaceutical composition
AU3586401A (en) Pharmaceutical composition
AU1748001A (en) Pharmaceutical composition for treatment of diarrhea
AU2001260083A1 (en) New pharmaceutical composition and the process for its preparation
HUP0104968D0 (en) Transdermal pharmaceutical composition containing aspirine for the treatment of sclerosis
IL135993A0 (en) Pharmaceutical composition for the treatment of fibrosis
AU5416500A (en) Pharmaceutical composition for the treatment of calcification
AUPR529701A0 (en) Pharmaceutical composition
AU2002250845A1 (en) Pharmaceutical composition for treating multiple sclerosis

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase